TECHNOLOGYISOLATING AND VISUALIZING RARE CELLS
Single Cell Pathology™
X-ZELL’s patented and proprietary platform technology – we call it Single Cell Pathology™ – is able to isolate and visualize a variety of rare cells in a small 10ml blood sample – including tumour-derived Circulating Endothelial Cells (CEC), Circulating Tumor Cells (CTC) and circulating tumour microemboli [3,4,5].
It is based on four core modules, all of which have been developed in-house and are now being made available to clinical study sites in Thailand and abroad, as well as select hospitals in Thailand.
Proprietary Cell Lysis
hMX™ Magnetic Cell Separation
Automated Microscopic Analysis
X-ZELL has refined semi-automated widefield fluorescence microscopy to identify and analyze cancer cells on a standard laboratory slide – allowing for classic cancer pathology to be applied to circulating tumour-derived cells at the single cell level. Well-described hallmarks of cancer can be re-discovered in isolated cancer cells and cell clumps, including aneuploidy, polyploidy, the expression of stem cell markers, mesenchymal makers, epithelial markers, cell proliferation markers, apoptotic markers and more, enabling diagnostics based on solid visual evidence.
Get in Touch
Use the form below to contact us for more information.